BIIB Jan 2025 260.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:48AM EDT. Market open.
Loading interactive chart…
- Zacks
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
GSK and Biogen (BIIB) are in the spotlight following litigation updates and drug approval, respectively.
- Zacks
Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.